FITC-labeled α4β1-specific probe, 4-((N′-2-methylphenyl)ureido)-phenylacetyl-L-leucyl-L-aspartyl-L-valyl-L-prolyl-L-alanyl-L-alanyl-L-lysine (FITC-LDVP) and its unlabeled version (LDVP), were from Tocris Bioscience (Avonmouth, Bristol, UK). Human VCAM D1D2 (mature residues F1 to T202) were expressed and purified from HEK 293S GnTI−/− cell line supernatants by affinity chromatography and gel filtration (Yu et al., 2013 (link)). VCAM D1D2 was fluorescently labeled with Alexa Fluor 488 NHS Ester (Thermo Fisher Scientific). Human Fn39-10 S1417C mutant (mature residues G1326 to T1509) and its synergy and RGD site (R1374A&P1376A&R1379A&S1417C&Δ1493-1496) mutated inactive version were expressed in Escherichia coli and purified as described (Li et al., 2017 (link); Takagi et al., 2001 (link)). Fn39-10 S1417C mutant was fluorescently labeled with Alexa Fluor 488 C5 maleimide (Thermo Fisher Scientific) at residue Cys-1417. Both Fn39-10 S1417C mutant and its inactive version were biotinylated with Maleimide-PEG11-Biotin at residue 1417 (Thermo Fisher Scientific) in PBS.
Free full text: Click here